Specialty Pharmacy

Researchers created a model framework to compare costs of 7 common regimens to treat relapsed and/or refractory multiple myeloma.

Viekirax and Exviera combination showed promising results in the treatment of patients with chronic HCV genotype 1b with compensated cirrhosis.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses methods specialty pharmacies can use to help patients access high cost medications.

Combination of sialidase and cucurbitacin I shows substantial antitumor activity in sarcoma therapy.

Drugs like Viagra could improve insulin sensitivity and secretion without diminishing fibrinolytic function.

Toll-like receptor 4 behave differently on psoriasis skin compared with uninvolved skin.

Top stories of the week on The American Journal of Pharmacy Benefits.

The combined impact of anti-cancer treatments and exercise holds promise for shrinking tumors.

Recent advances and updates in oncology and cancer drug development.

Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences.

High doses of biotin show promise in progressive multiple sclerosis.

Everolimus (Afinitor) treats progressive, non-functional neuroendocrine tumors of gastrointestinal or lung origin.

Gazyva plus bendamustine provides a new option to significantly reduce the risk of death.

The management of individual chemotherapy regimens by pharmacists improves safety by reducing medication errors.

FDA approval for Gazyva gives new option to patients with follicular lymphoma who did not respond to a regimen containing rituximab (Rituxan).

Researchers compare side effects for top selling hep C medications Zepatier, Sovaldi, Harvoni, and Viekira Pak.

Researchers compare top selling hep C medications Zepatier, Sovaldi, Harvoni, and Viekira Pak.

Cytokine IL-36 found to drive some inflammatory processes while helping to resolve the inflammation in IBD patients.

Researchers evaluate impact of medical cannabis on conditions such as rheumatoid arthritis, fibromyalgia and osteoarthritis.

Top stories of the week on Specialty Pharmacy Times.

Personal concerns about HIV status jeopardizing existing relationships could affect patient adherence behaviors.

The impact of pharmacist-led medication management services in the treatment chronic diseases.

Military veteran tried to manage the symptoms of hepatitis C treatment before Harvoni cured him of the disease.

Early lineage T cells show promise in the treatment of acute lymphoblastic leukemia.

Interferon therapy not recommended for patients with minimal cancer in one lymph node.

Medicare Part D plans are increasingly creating smaller networks of pharmacies within larger networks that offer lower cost-sharing arrangements.

Anti-inflammatory phytochemical in green tea shows promise in blocking the effects of RA.

Jury orders Johnson & Johnson to pay $72 million in damages to the family of a woman who died from ovarian cancer allegedly caused by products containing talcum powder.